Mecanismos de señalización celular en enfermedades hepáticas, cardiovasculares y cáncer
University of Giessen
Giessen, AlemaniaPublications in collaboration with researchers from University of Giessen (6)
2019
-
Deep Learning Reveals Cancer Metastasis and Therapeutic Antibody Targeting in the Entire Body
Cell, Vol. 179, Núm. 7, pp. 1661-1676.e19
2018
-
Corrigendum to “European contribution to the study of ROS: A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS)” (Redox Biol. (2017) 13 (94–162)(S2213231717303373)(10.1016/j.redox.2017.05.007))
Redox Biology
-
PHD3 controls lung cancer metastasis and resistance to EGFR inhibitors through TGFa
Cancer Research, Vol. 78, Núm. 7, pp. 1805-1819
2017
-
European contribution to the study of ROS: A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS)
Redox Biology, Vol. 13, pp. 94-162
2016
-
EphrinB2 repression through ZEB2 mediates tumour invasion and anti-angiogenic resistance
Nature Communications, Vol. 7
2014
-
Loss of PHD3 allows tumours to overcome hypoxic growth inhibition and sustain proliferation through EGFR
Nature Communications, Vol. 5